erythropoiesis stimulating agents and other growth factors in low-risk mds: an update
Published 8 years ago • 1.3K plays • Length 23:17Download video MP4
Download video MP3
Similar videos
-
4:51
understanding erythropoiesis
-
6:04
erythropoietin
-
3:44
erythropoiesis-stimulating agents in mds
-
4:45
erythropoiesis-stimulating agents for lower-risk mds
-
18:14
novel treatment strategies in low-risk mds: challenges and emerging therapies
-
1:33
what are erythropoietin-stimulating agents (esas)?
-
16:33
management of erythropoiesis-stimulating agent (esa)-refractory, lr-mds with rs
-
21:55
a unified approach to lower risk mds: standard and emerging therapies
-
25:10
management of lower-risk mds without del5q and refractory to esas
-
1:34
sequencing of agents in lr-mds
-
20:12
hematopoiesis | erythropoiesis
-
5:17
esa and other growth factors for mds
-
55:51
treating mds in young adults
-
6:33
managing and treating mds-related anemia
-
7:10
understanding mds-related anemia
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
6:33
myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology
-
5:56
transfusion-dependant, low-risk mds: what are the options?